Article Details

Royal Bank of Canada Reaffirms “Outperform” Rating for NewAmsterdam Pharma (NASDAQ:NAMS)

Retrieved on: 2025-01-26 11:17:05

Tags for this article:

Click the tags to see associated articles and topics

Royal Bank of Canada Reaffirms “Outperform” Rating for NewAmsterdam Pharma (NASDAQ:NAMS). View article details on hiswai:

Excerpt

Millennium Management LLC now owns 1,165,429 shares of the company's stock valued at $22,388,000 after acquiring an additional 217,902 shares during ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up